imatinib mesylate has been researched along with Epilepsy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, S; Singh, TG | 1 |
| Endo, F; Jono, H; Kouroki, M; Ohmura, T; Saito, H; Taguchi, K | 1 |
| Madrid, EM; Mahanty, S; Nash, TE | 1 |
3 other study(ies) available for imatinib mesylate and Epilepsy
| Article | Year |
|---|---|
Imatinib Attenuates Pentylenetetrazole Kindled and Pilocarpine Induced Recurrent Spontaneous Seizures in Mice.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Epilepsy; Imatinib Mesylate; Mice; Pentylenetetrazole; Pilocarpine; Seizures; Status Epilepticus; Valproic Acid | 2023 |
Carbamazepine-imatinib interaction in a child with chronic myeloid leukemia.
Topics: Anticonvulsants; Carbamazepine; Child; Drug Interactions; Epilepsy; Humans; Imatinib Mesylate; Leukemia, Myeloid; Male; Protein Kinase Inhibitors | 2014 |
Quantitative screening for anticestode drugs based on changes in baseline enzyme secretion by Taenia crassiceps.
Topics: Alkaline Phosphatase; Animals; Anticestodal Agents; Artemisinins; Artesunate; Benzamides; Epilepsy; Glucose-6-Phosphate Isomerase; Humans; Imatinib Mesylate; Neurocysticercosis; Nitro Compounds; Parasitic Sensitivity Tests; Piperazines; Praziquantel; Protein Kinase Inhibitors; Pyrimidines; Taenia; Thiazoles | 2013 |